Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study

Journal of Advanced Research

Volumn 7, Issue 3, 2016, Pages 423-434

  Shah, Nirmal V ^a   Seth, Avinash K ^a   Balaraman, R ^a   Aundhia, Chintan J ^a   Maheshwari, Rajesh A ^a   Parmar, Ghanshyam R ^a  

^a K M SHAH DENTAL COLLEGE AND HOSPITAL   (India)

Author keywords

Amorphous nature; Bioavailability; Lipid carrier; Pharmacokinetic parameters; Poor solubility; Transmission electron microscopy

Indexed keywords

EID: 84962561121     PISSN: 20901232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jare.2016.03.002     Document Type: Article

References (40)

1. Ettinger B., Black D.M., Mitlak B.H., Knickerbocker R.K., Nickelsen T., Genant H.K., et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 1999, 282:637-645.
2. Riggs B.L., Hartmann L.C. Selective estrogen-receptor modulators-mechanisms of action and application to clinical practice. N Engl J Med 2003, 348:618-629.
3. Patil P.H., Belgamwar V.S., Patil P.R., Surana S.J. Solubility enhancememt of raloxifene using inclusion complexes and cogrinding method. J Pharm 2013, 1-9.
4. O'Driscoll C.M., Griffin B.T. Biopharmaceutical challenges associated with drugs with low aqueous solubility - the potential impact of lipid-based formulations. Adv Drug Delivery Rev 2008, 60:617-624.
5. Khoo H.M., Shackleford D.M., Porter C.J.H., Edwards G.A., Charman W.N. Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs. Pharm Res 2003, 20(9):160-165.
6. Carmona-Ribeiro A.M. Biomimetic nanoparticles: preparation, characterization and biomedical applications. Int J Nanomed 2010, 5:249-259.
7. Radtke M., Souto E.B., Muller R.H. Nanostructured lipid carriers: a novel generation of solid lipid drug carriers. Pharm Technol Eur 2005, 17(4):45-50.
8. Muller R.H., Radtke M., Wissing S.A. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002, 242(1-2):121-128.
9. Hejri A., Khosravi A., Gharanjig K., Hejazi M. Optimization of formulation of β-carotene loaded nanostructured lipid carriers prepared by solvent diffusion method. Food Chem 2013, 141:117-123.
10. Kushwaha A.K., Vuddanda P.R., Karunanidhi P., Singh S.K., Singh S. Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. Biomed Res Int 2013, 1-9.
11. Shete H., Patravale V. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization. Int J Pharm 2013, 454:573-583.
12. Burra M., Jukanti R., Janga K.Y., Sunkavalli, Velpula A., Ampati S., et al. Enhanced intestinal absorption and bioavailability of raloxifene hydrochloride via lyophilized solid lipid nanoparticles. Adv Powder Technol 2013, 24:393-402.
13. Patel D., Dasgupta S., Dey S., Ramani Y.R., Ray S., Mazumder B. Nanostructured lipid carrier (NLC)-based gel for the topical delivery of aceclofenac: preparation, characterization and in vivo evaluation. Sci Pharm 2012, 80:749-764.
14. Shah K.A., Date A.A., Joshi M.D., Patravale V.B. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm 2007, 345:163-171.
15. Sharma P., Ganta S., Denny A.W., Garg S. Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative. Chlorambucil. Int J Pharm 2009, 367:187-194.
16. Bhalekar M.R., Pokharkar V., Madgulkar A., Patil N. Preparation and evaluation of miconazolenitrate loaded solid lipid nanoparticles for topical delivery. AAPS PharmSciTech 2009, 10:289-296.
17. Elsheikh M.A., Elnaggar Y.S.R., Gohar E.Y., Abdallah O.Y. Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal. Int J Nanomed 2012, 7:3787-3802.
18. Thakkar H., Nangesh J., Parmar M., Patel D. Formulation and characterization of lipid- based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery system. J Pharm Bioallied Sci 2011, 3(3):442-448.
19. Shishu, Rajan S., Kamalpreet Development of novel microemulsion-based topical formulations of acyclovir for the treatment of cutaneous herpetic infections. AAPS PharmSciTech 2009, 10(2):559-565.
20. Hu F.Q., Jiang S.P., Du Y.Z., Yuan H., Ye Y.Q., Zeng S. Preparation and characteristic of monostearin nanostructured lipid carriers. Int J Pharm 2006, 314:83-89.
21. Sanad R.A., AbdelMalak N.S., elBayoomy T.S., Badawi A.A. Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs). AAPS PharmSciTech 2010, 11(4):1684-1694.
22. Hu F.Q., Jiang S.P., Du Yuan H., Ye Y.Q., Zeng S. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B Biointerfaces 2005, 45:167-173.
23. Hu F.Q., Zhang Y., Du Y.Z., Yuan H. Nimodipine loaded lipid nanospheres prepared by solvent diffusion method in a drug saturated aqueous system. Int J Pharm 2008, 348:146-152.
24. Joshi M., Pathak S., Sharma S., Patravale V. Design and invivo pharmacodynamics evaluation of nanostructured lipid carriers for parenteral delivery of artemether: nanoject. Int J Pharm 2008, 364:119-126.
25. Subedi R.K., Kang K.W., Choi H.K. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sci 2009, 37:508-513.
26. Ravi P.R., Aditya N., Kathuria H., Malekar S., Vats R. Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism. Eur J Pharm Biopharm 2014, 87:114-124.
27. Marques M.R.C., Loebenberg R., Almukainzi M. Simulated biological fluids with possible application in dissolution testing. Dissolut Technol 2011, 18(3):15-28.
28. Yang Z.Y., Zhang Z.F., He X.B., Zhao G.Y., Zhang Y.Q. Validation of a novel HPLC method for the determination of raloxifene and its pharmacokinetics in rat plasma. Chromatographia 2007, 65:197-201.
29. Tran T.H., Poudel B.K., Marasini N., Chi S.C., Choi H.G., Yong C.S., et al. Preparation and evaluation of raloxifene loaded solid dispersion nanoparticle by spray drying technique without an organic solvent. Int J Pharm 2013, 443:50-57.
30. Jha R.K., Tiwari S., Mishra B. Bioadhesive microspheres for bioavailability enhancement of raloxifene hydrochloride: formulation and pharmacokinetics evaluation. AAPS PharmSciTech 2011, 12(2):650-657.
31. Jia L., Zhang D., Li Z., Duan C., Wang C., Wang Y., et al. Nanostructured lipid carriers for parenteral delivery of silybin: biodistribution and pharmacokinetic studies. Colloids Surf B Biointerfaces 2010, 80:213-218.
32. Li F., Wang Y., Liu Z., Lin X., He H., Tang X. Formulation and characterization of bufadienolides-loaded nanostructured lipid carriers. Drug Dev Ind Pharm 2010, 36:508-517.
33. Jenning V., Thunemann A.F., Gohla S.H. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 2000, 199:167-177.
34. Jenning V., Gohla S.H. Encapsulation of retinoids in solid lipid nanoparticles (SLN). J Microencapsul 2001, 18:149-158.
35. Souto E.B., Wissing S.A., Barbosa C.M., Muller R.H. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004, 278:71-77.
36. Muhlen A.Z., Muhlen E.Z., Niehus H., Mehnert W. Atomic force microscopy studies of solid lipid nanoparticles. Pharm Res 1996, 13:1411-1416.
37. Garcia-Fuentes M., Torres D., Alonso M.J. Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloids Surf B 2003, 27:159-168.
38. Westesen K., Bunjes H., Koch M.H.J. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Controlled Release 1997, 48(2-3):223-236.
39. Thakkar H., Patel B., Thakkar S. A review on techniques for oral bioavailability enhancement of drugs. Int J Pharm Sci Rev Res 2010, 4(3):203-223.
40. Aungst B.J., Myers M.J., Shefter E., Shami E.G. Prodrugs for improved oral nalbuphine bioavailability: inter-species differences in the disposition of nalbuphine and its acetylsalicylate and anthranilate esters. Int J Pharm 1987, 38(1-3):199-209.